KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,548,000 | +194.3% | 150,000 | +200.0% | 0.43% | +184.0% |
| Q1 2021 | $526,000 | -66.0% | 50,000 | -50.0% | 0.15% | -67.4% |
| Q4 2020 | $1,548,000 | -39.4% | 100,000 | -42.9% | 0.46% | -41.1% |
| Q3 2020 | $2,555,000 | +79.8% | 175,000 | +133.3% | 0.78% | +83.3% |
| Q2 2020 | $1,421,000 | -26.0% | 75,000 | -25.0% | 0.43% | -49.6% |
| Q1 2020 | $1,921,000 | -71.0% | 100,000 | -71.0% | 0.85% | -67.1% |
| Q4 2019 | $6,614,000 | – | 345,000 | – | 2.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |